Abstract:Baculovirus has been widely used for the production of recombinant proteins in insect cells. The extremely high yield by baculovirus-infected insect cells or larvae makes it an attractive tool for pharmaceutical protein production. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. Although AcMNPV (Autographa californica multiple NPV) fails to replicate in vertebrate cells, it does express alien genes with levels of expression that are dependent on the strength of the promoter used to drive transcription of the foreign gene. Following these findings, subsequent studies have rapidly expanded the list of permissive cells that include cell lines originating from human, rodent, porcine, bovine and even fish sources. Many tries have been done to study the mechanism of baxulovirus entry into mammalian cells, but the events responsible for virus uptake and detailed mechanisms of intracellular movement and nuclear entry of the virus are still largely unknown. The application of modified baculoviruses for in vivo gene delivery has also been demonstrated. In contrast to other commonly used viral vectors, baculoviruses have the unique property of being incapable of initiating a replication cycle and producing infectious virus in mammalian cells. The AcMNPV genome is large, thus rendering the virus flexibility to carry multiple genes or large inserts. The recombinant viruses can be readily constructed and produced to high titers simply by infecting insect cells, initiate little to none microscopically observable cytopathic effects on mammalian cells and have a good biosafety profile. These attributes will undoubtedly lead to the increased application and continued development of this system for efficient gene delivery into mammalian cells.

Soluble Cytoplasmic Expression, Rapid Purification, and Characterization of Cyanovirin-N As a His-SUMO Fusion

[Expression, purification and activity determination of cyanovirin-N].

The Antiviral Protein Cyanovirin-N: the Current State of Its Production and Applications

蓝藻抗病毒蛋白-N基因的克隆、表达、纯化及活性鉴定

[Purification of Cyanovirin-N with Antiviral Activity and Preparation As Well As Modification of Its Polyclonal Antibody].

Significantly Improved Recovery Of Recombinant Sonchus Yellow Net Rhabdovirus By Expressing The Negative-Strand Genomic Rna

Design of fusion protein for efficient preparation of cyanovirin-n and rapid enrichment of pseudorabies virus

Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

Soluble Expression in Escherichia coli and Purification of Recombinant Scytovirin

Preparation of Monopegylated Cyanovirin-N's Derivative and Its Anti-Influenza A Virus Bioactivity in Vitro and in Vivo.

Progress in Research of the Anti-Hiv Inhibitor Cyanovirin-N

High-level expression and characterization of an anti-VEGF165 single-chain variable fragment (scFv) by small ubiquitin-related modifier fusion in Escherichia coli

Use of the SUMO Expression System to Efficiently Express the Soluble VP3 Protein of Infectious Bursal Disease Virus

A novel application of baculovirus in mammalian gene therapy]

Capped Antigenomic RNA Transcript Facilitates Rescue of a Plant Rhabdovirus

Rational Design of Translational Pausing Without Altering the Amino Acid Sequence Dramatically Promotes Soluble Protein Expression: a Strategic Demonstration.

Soluble expression, rapid purification, and characterization of human interleukin-24 (IL-24) using a MBP-SUMO dual fusion system in Escherichia coli

Cell-free synthesis and purification of recombinant nucleocapsid (N), membrane (M), and envelope (E) proteins

Engineering recombinantly expressed lectin-based antiviral agents

Expression, Purification, and Partial Characterization of HCV RNA Polymerase

Construction of expression vectors for efficient expression of soluble recombinant proteins]